Christian T. Darabant
Executive Vice President and Chief Operating Officer
DarabantC
Christian Darabant is the Executive Vice President and Chief Operating Officer of HuREL Corporation. Throughout his 20-year career in life sciences, Mr. Darabant has held progressively responsible leadership roles focused on developing commercial strategies to drive global revenues. Mr. Darabant is known as a forward-thinking and entrepreneurial executive, with a demonstrated track record of success in driving enterprise value through both organic and inorganic growth. An inclusive leader, he works collaboratively to innovate, design and deliver strategic hypotheses that align with organizational goals. He finds his greatest reward in developing and inspiring team members.



HµRELToxTM
multi-readout, repeat-dose
DILI screening
DILI screening

Hurel microlivers afford better prediction than 3D

Toxicology Research
HµRELviralTM
Long-enduring infectious liver disease platform
Time-Based
Toxicity Ratios*
A new marker for hepatotoxic chronicity

TAAP
*patent pending
HµRELfluxTM
a new, patent-pending
efflux transport
assay method
DMPK
Superior intrinsic clearance
and biotransformation of
low-turnover drugs

DMD